Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis

Abstract

Experimental Autoimmune Encephalomyelitis (EAE) is the most commonly used animal model for Multiple Sclerosis (MScl). CSF metabolomics in an acute EAE rat model was investigated using targetted LC–MS and GC–MS. Acute EAE in Lewis rats was induced by co-injection of Myelin Basic Protein with Complete Freund’s Adjuvant. CSF samples were collected at two time points: 10 days after inoculation, which was during the onset of the disease, and 14 days after inoculation, which was during the peak of the disease. The obtained metabolite profiles from the two time points of EAE development show profound differences between onset and the peak of the disease, suggesting significant changes in CNS metabolism over the course of MBP-induced neuroinflammation. Around the onset of EAE the metabolome profile shows significant decreases in arginine, alanine and branched amino acid levels, relative to controls. At the peak of the disease, significant increases in concentrations of multiple metabolites are observed, including glutamine, O-phosphoethanolamine, branched-chain amino acids and putrescine. Observed changes in metabolite levels suggest profound changes in CNS metabolism over the course of EAE. Affected pathways include nitric oxide synthesis, altered energy metabolism, polyamine synthesis and levels of endogenous antioxidants.Electronic supplementary materialThe online version of this article (doi:10.1007/s11306-011-0306-3) contains supplementary material, which is available to authorized users.

Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation

“…In addition to γ-glutamyl metabolites, WGCNA also identified multiple branched chain amino acids and phenylalanine and lysine metabolites that were altered in MS patients. Metabolomics studies in rodent EAE have demonstrated changes in branched chain amino acid and histidine metabolism (20,21). Previous studies in MS patients have also noted differences in amino acid metabolism (branched-chain amino acid, alanine, arginine) (22,23) or in multiple amino acids (tryptophan, alanine, and isoleucine) in addition to energy metabolites (24).…”

Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation

“…A similar strategy involving oral formulation of high dose biotin, which serves as a cofactor for essential carboxylase enzymes required for fatty acid synthesis, has recently been demonstrated to provide benefit in patients with not-active progressive multiple sclerosis 39 . Intriguingly, taurine has previously been identified as a dysregulated metabolite in animal models of multiple sclerosis disease, including nonhuman primate models 40 , and its plasma levels can be used to distinguish PLP-induced experimental autoimmune encephalomyelitis (EAE) mice from naive controls 41–44 . At a minimum, these findings demonstrate the utility of global metabolomic analyses in the identification of endogenous metabolites that can serve to modulate cellular phenotypes.…”

Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology

“…The obtained metabolite profiling showed that around the onset of EAE, arginine, alanine and branched amino acid levels were significantly decreased compared with normal controls. Whereas, at the peak of the disease, glutamine, O-phosphoethanolamine, branchedchain amino acids and putrescine were significantly increased (Noga et al, 2012). LC/MS and GC/MS can separate different metabolites basing on whether these metabolites can be volatile or derivatized.…”